The Cigna Group (CI)
| Market Cap | 81.84B |
| Revenue (ttm) | 247.12B |
| Net Income (ttm) | 3.43B |
| Shares Out | 278.15M |
| EPS (ttm) | 12.29 |
| PE Ratio | 23.95 |
| Forward PE | 9.69 |
| Dividend | $6.04 (2.05%) |
| Ex-Dividend Date | Mar 5, 2025 |
| Volume | 3,245,765 |
| Open | 284.71 |
| Previous Close | 282.98 |
| Day's Range | 282.03 - 299.64 |
| 52-Week Range | 262.03 - 370.83 |
| Beta | 0.55 |
| Analysts | Strong Buy |
| Price Target | 382.39 (+29.97%) |
| Earnings Date | Jan 30, 2025 |
About CI
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company’s Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other product... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 18 analysts, the average rating for CI stock is "Strong Buy." The 12-month stock price forecast is $382.39, which is an increase of 29.97% from the latest price.
News
The Cigna Group (CI) Q4 2024 Earnings Call Transcript
The Cigna Group (NYSE:CI) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants David Cordani - Cigna Group's Chairman, Chief Executive Officer Brian Evanko - Chief Financ...
Cigna misses quarterly profit estimates on higher medical costs
Cigna forecast annual profit below Wall Street expectations on Thursday and missed estimates for the fourth quarter, hurt by higher medical costs for a type of employer-sponsored healthcare plan.
Cigna 2024 Profits Eclipse $3 Billion Despite Rising Costs
The Cigna Group Thursday reported more than $3.4 billion in 2024 net income including $1.4 billion in the fourth quarter as the health insurer worked to overcome rising medical expenses in its employe...
The Cigna Group Reports Fourth Quarter and Full Year 2024 Results, Establishes 2025 Outlook and Increases Dividend
Total revenues for 2024 increased 27% to $247.1 billion Shareholders' net income for 2024 was $3.4 billion, or $12.12 per share Adjusted income from operations1 for 2024 was $7.7 billion, or $27.33 pe...
Cigna Healthcare, Providence to Broaden Southern California Network
Greater Flexibility, More Health Care Options for Customers LOS ANGELES , Jan. 29, 2025 /PRNewswire/ -- Cigna Healthcare and Providence are expanding their Los Angeles County network, offering custome...
Cigna to take steps to lower out-of-pocket costs of prescription drugs
Cigna's unit Evernorth Health said on Wednesday it will take several steps to help lower out-of-pocket cost of prescription drugs for patients at its pharmacy stores.
Evernorth Announces New Cost and Transparency Protections for its Express Scripts Patients
Actions aim to lower patient out-of-pocket costs Expands transparency for both patients and those who provide their benefits BLOOMFIELD, Conn. , Jan. 29, 2025 /PRNewswire/ -- Evernorth Health Services...
Barclays' Andrew Mok: Any sustained underperformance in big tech will likely benefit healthcare
Andrew Mok, Barclays director of equity research, joins CNBC's 'The Exchange' to discuss why healthcare may offer opportunity as tech stocks are under pressure from China competition.
Can The Magnificent 7 Maintain An Upbeat Earnings Season?
The Q4 earnings season continued on a positive note after big banks and other financials struck a bullish tone in the first two weeks of reporting. Highly anticipated reports from the Magnificent 7 wi...
Cigna: Buy The Drop On This Undervalued Growth Stock
Cigna's current valuation presents a compelling opportunity, trading at a forward PE of 9.9, significantly below its historical average of 12.0x. The company carries diversified revenue streams and co...
Focus On Costs, Regulatory Outlook For Health Insurers In Q4'24 Earnings Season
Most publicly traded US health insurers are forecast to report sequential revenue and earnings declines for the fourth quarter of 2024, according to S&P Global Market Intelligence analysis of sell-sid...
The Cigna Group's Fourth Quarter 2024 Earnings Release Details
BLOOMFIELD, Conn. , Jan. 14, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2024 financial results on Thursday, January 30, 2025, and will host a ...
Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services
BLOOMFIELD, Conn. , Jan. 13, 2025 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), today announced a new offering in collaboration with Progyny, Inc (Nasda...
Market Madness: 3 Blue-Chip Dividend Steals You Can't Ignore
The U.S. economy added 256,000 jobs last month, far exceeding expectations, which suggests a strong economy but reduces the likelihood of further Fed rate cuts. Rising long-term rates increase borrowi...
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Employers are increasingly requiring workers on GLP-1 medications to enroll in nutrition and lifestyle coaching programs. Startup Virta Health saw 60% revenue growth last year, topping $100 million, d...
The Cigna Group Foundation Supports Mental Health and Housing Stability for Veterans, Announcing First Round of Grant Recipients
BLOOMFIELD, Conn. , Jan. 8, 2025 /PRNewswire/ -- The Cigna Group Foundation announced today 22 recipients for the first year of its new grant program that aims to improve veteran mental health with a ...
Former Cigna VP: Health insurance industry has erect barriers making it more difficult to seek care
Wendell Potter, Center for Health and Democracy president and former Cigna vice president, joins 'Squawk Box' to discuss public anger at the health care industry, problems with health insurance, and m...
Humana, Cigna Plunge On Trump's Latest Promise: A Potential Buying Opportunity?
The healthcare industry, particularly PBMs, faces bipartisan scrutiny, leading to significant stock declines for Humana and Cigna, presenting a contrarian investment opportunity. President-elect Donal...
UnitedHealth, CVS, and Cigna stock prices take another hit after Trump says he's going to ‘knock out' drug industry middlemen
Shares in major healthcare companies fell yesterday after president-elect Donald Trump made comments that he wanted to “knock out” prescription drug industry middlemen. The fall makes this yet another...
Insurer stocks fall after Trump says 'we're going to knock out the middleman'
Shares of health insurers operating pharmacy benefit managers fell on Monday after U.S. President-elect Donald Trump called them middlemen who drive up costs and said he plans to eliminate their role.
Cigna: I'm Loading Up On This Dividend Growth Stock Now
Cigna's strong fundamentals, including consistent revenue and EPS growth, a solid balance sheet, and undervalued stock price, support a buy rating. The company's Q3 results showed a 29.9% revenue incr...
J&J accuses divisions of Cigna of helping drain its drug copay funds, WSJ reports
Johnson & Johnson has sued divisions of Cigna , accusing the health insurer of working with a drug-benefit middleman to drain J&J's financial-assistance funds earmarked for patients taking some of its...
Senators Warren and Hawley introduce a bipartisan bill to break up pharmacy-benefit managers
CNBC's Bertha Coombs joins ‘The Exchange' to discuss a bipartisan bill introduced by Senators Elizabeth Warren and Josh Hawley aimed at breaking up pharmacy-benefit managers.
Cigna's stock leads selloff among drug middlemen on breakup fears — but this analyst says it's not a real risk
One influential healthcare analyst says the chances of such a bill passing are less than 5%.